AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own TransUnion, you need to believe in its role at the center of global credit and identity data, and in its ability to monetize AI‑enhanced analytics without eroding trust. The new Canadian class action sharpens the near term risk around data accuracy and compliance, while the key catalyst remains execution on its AI and OneTru product stack. At this stage, the dividend decision itself does not appear to materially change that near term setup.
The latest quarterly dividend of US$0.1250 per share, alongside ongoing buybacks, is the most relevant announcement here because it highlights TransUnion’s commitment to returning capital even as legal scrutiny rises. With analysts previously highlighting solid earnings and free cash flow, this payout stance sits squarely in the middle of the debate about whether cash should prioritize growth investments, balance sheet strength, or potential litigation and compliance costs.
Yet, behind the AI growth story, the emerging legal and data quality questions are information investors should be aware of before they decide whether...
Read the full narrative on TransUnion (it's free!)
TransUnion’s narrative projects $5.9 billion revenue and $852.5 million earnings by 2029.
Uncover how TransUnion's forecasts yield a $92.29 fair value, a 34% upside to its current price.
Some of the most optimistic analysts were assuming revenue could reach about US$6.7 billion and earnings around US$894.5 million, but the new class action and the risk that heavy AI investment might not translate into the expected premium data demand show how far views can differ and why you should compare these bullish assumptions with your own expectations.
Explore 2 other fair value estimates on TransUnion - why the stock might be worth over 2x more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Our daily scans reveal stocks with breakout potential. Don't miss this chance:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Contact Us
Contact Number :+852 3852 8500
English